VCU researcher leads interdisciplinary NIH-funded effort to build fairer measures of value for Alzheimer’s drugs
As the federal government prepares to negotiate prescription drug prices for the first time, a VCU College of Health Professions researcher is leading an effort to determine whether current methods for judging the “value” of new Alzheimer’s treatments are accurate — and whether they disadvantage vulnerable older adults.